Therapy/Class: Anti-Glaucoma
Mechanism of Action:
Brinzolamide: A specific, reversible, non-competitive inhibitor of carbonic anhydrase II (CA-II) in the ciliary epithelium. By slowing the formation of bicarbonate ions, it reduces sodium and fluid transport, directly inhibiting aqueous humor production.